Caligan Partners LP
CIK: 0001727492SEC EDGAR →
Portfolio Value
$1.2B
Holdings
21
As of
Q4 2025
New Positions
4
Closed Positions
4
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | 8,118,892 | $280.0M | 23.05% |
| 2 | ABIVAX SA | 1,451,924 | $195.8M | 16.12% |
| 3 | MLYSPut MINERALYS THERAPEUTICS INC | 5,071,054 | $184.0M | 15.15% |
| 4 | REVOLUTION MEDICINES INC | 1,283,900 | $102.3M | 8.42% |
| 5 | VAXCYTE INC | 1,704,815 | $78.7M | 6.48% |
| 6 | EXELIXIS INC | 1,553,262 | $68.1M | 5.60% |
| 7 | ADMA BIOLOGICS INC | 3,012,508 | $54.9M | 4.52% |
| 8 | XENEPut XENON PHARMACEUTICALS INC | 1,099,365 | $49.3M | 4.06% |
| 9 | INBXCall INHIBRX BIOSCIENCES INC | 473,565 | $37.4M | 3.08% |
| 10 | TANGO THERAPEUTICS INC | 3,729,895 | $33.0M | 2.72% |
Quarterly Changes
New Positions (12)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 20 | $1.1B | 94.4% |
| Unknown | 1 | $68.1M | 5.6% |